Publications
Partners
Shutterstock
Leading scientists have released the latest results of the large scale trials related to nuts consumption and health, particularly in myocardial infarction, stroke and cardiovascular diseases.
Recent scientific studies show the benefits of regular intake of nuts, not only associated with cardiovascular health but also with renal function, diabetes, cognitive function, atherosclerosis, metabolic syndrome and inflammatory biomarkers, among others.
The scientists said it was important to highlight that scientific evidence demonstrated that eating nuts was not associated with a higher risk of weight gain and even reinforce their importance as sources of key nutrients.
The international Nut and Dried Fruit Council said five leading researchers recently shared their findings at a symposium called "Nuts in Health and Disease".
A Predimed study focused on how a daily handful of nuts (15g of walnuts, 7.5g of hazelnuts and 7.5g of almonds) reduced by 28% the incidence of cardiovascular disease (myocardial infarction, stroke and cardiovascular death).
Dr Mònica Bulló, the main researcher at the Epirdem project, concluded that a regular intake of pistachios had a direct effect on the reduction of incidence of type 2 diabetes.
Pistachios have been studied in relation to their lipid profile and other risk factors of cardiovascular disease to evaluate their effect on glucose metabolism, insulin resistance and the risk of type 2 diabetes.
The key results of a epidemiological study on nuts and their effect on chronic diseases were presented by Professor Frank Hu from Harvard University, showing how increasing nut consumption (greater than or equal to five times per week) was associated with a 30% lower risk of cardiovascular disease.
Professor Linda Tapsell of the Wollongong University in Australia, announced that nut consumption was not associated with a higher risk of weight gain and recommended nuts as part of the diet to prevent obesity and other chronic diseases.
More information: Scientifically proven: nuts are not fattening
Photo: Assorted nuts from Shutterstock
Recent scientific studies show the benefits of regular intake of nuts, not only associated with cardiovascular health but also with renal function, diabetes, cognitive function, atherosclerosis, metabolic syndrome and inflammatory biomarkers, among others.
The scientists said it was important to highlight that scientific evidence demonstrated that eating nuts was not associated with a higher risk of weight gain and even reinforce their importance as sources of key nutrients.
The international Nut and Dried Fruit Council said five leading researchers recently shared their findings at a symposium called "Nuts in Health and Disease".
A Predimed study focused on how a daily handful of nuts (15g of walnuts, 7.5g of hazelnuts and 7.5g of almonds) reduced by 28% the incidence of cardiovascular disease (myocardial infarction, stroke and cardiovascular death).
Dr Mònica Bulló, the main researcher at the Epirdem project, concluded that a regular intake of pistachios had a direct effect on the reduction of incidence of type 2 diabetes.
Pistachios have been studied in relation to their lipid profile and other risk factors of cardiovascular disease to evaluate their effect on glucose metabolism, insulin resistance and the risk of type 2 diabetes.
The key results of a epidemiological study on nuts and their effect on chronic diseases were presented by Professor Frank Hu from Harvard University, showing how increasing nut consumption (greater than or equal to five times per week) was associated with a 30% lower risk of cardiovascular disease.
Professor Linda Tapsell of the Wollongong University in Australia, announced that nut consumption was not associated with a higher risk of weight gain and recommended nuts as part of the diet to prevent obesity and other chronic diseases.
More information: Scientifically proven: nuts are not fattening
Photo: Assorted nuts from Shutterstock
